[Treatment of bone hydatidosis with mebendazole].
Explore the source record for details and available documents.
Benzimidazoles↗
Biomedical subjects
P Saballs
Publications and source records attributed to P Saballs.
[Bone hydatidosis with multi-organ involvement].
Explore the source record for details and available documents.
Bone Diseases↗
Renal infection due to Absidia corymbifera in an AIDS patient.
A case of renal zygomycosis due to Absidia corymbifera in an heroin addict suffering from AIDS (phase IV C2) is described. Diagnosis was by histopathology after nephrectomy, but A. corymbifera was isolated several times from urine and from the exudate from a fistula in the surgical wound. After amphotericin B treatment (1.5 g overall dose) clinical cure and negative cultures were obtained. No relapses were observed until death 1 year later from Pneumocystis carinii pneumonia.
AIDS-Related Opportunistic Infections↗
Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy.
PURPOSE: HIV-associated Kaposi's sarcoma (KS) may not resolve despite highly active antiretroviral therapy (HAART). Moreover, the therapeutic goal has shifted from palliative care to long-term durable complete remission. The objective of the study was to assess the impact of liposomal doxorubicin in the treatment of HIV-associated KS in the HAART era. METHOD: In this prospective, noncomparative, multicenter study, patients with more than 10 cutaneous lesions or visceral disease were treated with 20 mg/m(2) of liposomal doxorubicin (Caelyx) every 3 weeks in addition to their antiretroviral therapy. In addition to tumor measurements and laboratory tests, human herpes virus 8 (HHV-8) polymerase chain reaction (PCR) in peripheral blood mononuclear cells (PBMC) was performed. RESULTS: Out of 79 participants enrolled in the study, 47 (59%) had stage T(1), 41 (52%) I(1), and 32 (40%) S(1). Nine individuals were not evaluable for response, 32 (40%) had complete response, 30 (38%) partial response, 5 (6%) stable disease, and 3 (4%) progression. Regression analysis did not find any statistically significant factor predicting response. HHV-8 PCR was positive in 37/53 (70%) patients with available PBMC samples, and HHV-8 viremia cleared in 14/27 (52%) without correlation with clinical response. Eleven (14%) participants experienced a relapse of KS, while at the last update of data, 49 (62%) remained stable. The only risk factor for recurrence identified was the follow-up time (odds ratio [OR] 1.21, 95% CI 1.07-1.36; p =.002). CONCLUSION: The response rate of AIDS-associated KS to liposomal doxorubicin administered with HAART was high, and most often the response was durable. HHV-8 viremia did not correlate well with clinical outcome.
AIDS-Related Opportunistic Infections↗